Published Articles

Tunnell’s subject matter experts have written a number of informative pieces. Here are a sampling of articles that have been published in leading industry publications.

Information Management Strategies to Improve Data Integrity During M&As

  • November 2017
  • Life Science Leader
Tunnell Managing Consultant, Kip Wolf, discusses the challenges to M&A integration and maintaining business continuity, transferring appropriate knowledge, and transferring information assets.

In Defense of the Anti-Generic

  • June 2017
  • Pharma Manufacturing
This article in Pharmaceutical Manufacturing quotes Tunnell’s Scott Myers on the role of authorized generics in today’s competitive generics marketplace.

Quality Culture: Getting it Right the First Time

  • June 2017
  • Innovation Excellence
“Minimum viable product” may work well for software, but pharma needs to get it right the first time, and develop a culture of quality,

Integrating Technology Transfer and Facilities Startup for Biologics

  • April 2016
  • BioPharm International
The key to successful technology transfer and facility startup is in strong project management, and it may make all the difference.

Manufacturing’s True North: The Quality Compass

  • August 2015
  • Pharmaceutical Executive
Biopharma needs to combine a “culture of quality” with value-added process improvements in manufacturing.

Quality Agreements for Contract Manufacturers

  • September 2014
  • BioPharm
A well-constructed quality agreement can be an important tool to enable effective collaboration between owner and CMO.

Operational Excellence: More Than Just Process Improvement

  • October 2013
  • BioPharm
By embracing efficiency and quality, biopharmaceutical organizations can work better and achieve better work.

State of Quality and Compliance in the Biopharmaceutical Industry

  • April 2013
  • BioPharm
Have FDA initiatives improved manufacturing quality and patient safety?

Connecting QbD, Knowledge Management and Supplier Quality Management

  • November 2012
  • BioPharm International
Understanding overall supplier capability versus the critical-to-quality attributes of your product can reduce both risk and cost.

Through the Lens of Lean

  • October 2012
  • Pharmaceutical Manufacturing
October, 2012 – Lean may have been designed for manufacturing, but it can also transform quality control labs.

Reduce Analytical Testing and Costs Without Compromising Compliance

  • July 2012
  • BioPharm International
Unnecessary analytical testing can lead to unnecessary costs.

Risk Based Decision Making

  • March 2012
  • BioPharm International
Focusing on how risk affects the entire organization can improve the business bottom line.
Scroll to Top